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OBJECTIVES We sought to develop and validate a risk score combining both clinical and dobutamine
echocardiographic (DbE) features in 4,890 patients who underwent DbE at three expert
laboratories and were followed for death or myocardial infarction for up to five years.
BACKGROUND In contrast to exercise scores, no score exists to combine clinical, stress, and echocardiographic
findings with DbE.
METHODS Dobutamine echocardiography was performed for evaluation of known or suspected coronary
artery disease in 3,156 patients at two sites in the U.S. After exclusion of patients with
incomplete follow-up, 1,456 DbEs were randomly selected to develop a multivariate model
for prediction of events. After simplification of each model for clinical use, the models were
internally validated in the remaining DbE patients in the same series and externally validated
in 1,733 patients in an independent series.
RESULTS The following score was derived from regression models in the modeling group (160 events):
DbE risk  (age · 0.02)  (heart failure  rate-pressure product 15,000) · 0.4  (ischemia
 scar) · 0.6. The presence of each variable was scored as 1 and its absence scored as 0, except
for age (continuous variable). Using cutoff values of 1.2 and 2.6, patients were classified into
groups with five-year event-free survivals 95%, 75% to 95%, and 75%. Application of the
score in the internal validation group (265 events) gave equivalent results, as did its
application in the external validation group (494 events, C index  0.72).
CONCLUSIONS A risk score based on clinical and echocardiographic data may be used to quantify the risk of
events in patients undergoing DbE. (J Am Coll Cardiol 2004;43:2102–7) © 2004 by the
American College of Cardiology Foundationw
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fihe ability of functional testing to predict outcomes prom-
ses to guide the development of more cost-effective ap-
roaches to the treatment of coronary artery disease (CAD).
nlike the traditional binary approach to positive and
egative test results, the development of multivariate scores
ermits the assessment of disease probability and outcome,
sing a spectrum of increasingly abnormal findings (1). The
dditional data provided by these functional testing ap-
roaches has led them to be recommended as part of the
pproach to stress testing in the recent American College of
ardiology/American Heart Association guidelines (2). In-
eed, several studies of exercise testing scores have shown
hat their ability to predict outcome exceeds that of most
hysicians and is equal to that of experienced cardiologists
3). Other scores have added clinical data to the stress test
ndings, and these appear to have greater prognostic power
han the exercise data alone (4). Such a score has been
eveloped in patients followed after exercise echocardiogra-
hy (5), but this study was small, the events included minor
nd points, and there was no validation in an external group.
Cardiac stress imaging combinations have been used
From the *Department of Medicine, University of Queensland, Brisbane, Australia;
Thoraxcenter, Rotterdam, Netherlands; ‡Indiana University Hospital, Indianapolis,
ndiana; and §Cleveland Clinic Foundation, Cleveland, Ohio. This study was
upported in part by the American Society of Echocardiography and the National
eart Foundation of Australia.
Manuscript received November 18, 2003; revised manuscript received Decemberp0, 2003, accepted February 3, 2004.idely in situations where exercise electrocardiography
ECG) is either not feasible because of an inability to
xercise or suboptimal in situations where the ECG content
f the test is nondiagnostic due to resting ST-segment
hanges (6). Dobutamine stress echocardiography has been
hown to be an independent and incremental predictor of
dverse outcome (7–10), and the findings of negative and
ositive stress responses have been shown to be associated
ith various levels of risk, with implications for subsequent
anagement. However, no scores analogous to the tread-
ill score have been described using dobutamine echocar-
iography (DbE) techniques. We sought to develop and
alidate a prognostic score, taking into account both clinical
nd stress echocardiographic findings, that could facilitate
he further investigation and management of patients un-
ergoing DbE as their primary test.
ETHODS
atient selection. We studied consecutive patients under-
oing DbE at two high-volume echocardiography labora-
ories in the U.S. (Cleveland Clinic Foundation and Indiana
niversity Hospital) and validated the findings in a group of
atients studied during the same era at the Thoraxcenter
Rotterdam, the Netherlands). All patients had either
nown or suspected CAD, and clinical data, stress test
ndings, and echocardiographic data were all gathered
rospectively. The total group of 4,890 patients comprised
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June 2, 2004:2102–7 Risk Score With Dobutamine Echocardiography,156 studied in the U.S. (from 1988 to 1994) and 1,734
tudied in the Netherlands (from 1989 to 1997). At the
merican sites, the most common indication for testing was
isk evaluation after infarction (23%) and before noncardiac
urgery (37%); 544 (17%) had the test performed for the
valuation of chest pain. Known CAD was present in 941
atients (30%), reflecting a previous myocardial infarction
MI) in 23% and revascularization in 6%. In the Dutch
roup, the test was performed for diagnostic reasons in 707
atients (41%), for preoperative cardiac risk assessment in
22 (42%), and after infarction in 305 (21%). The relation-
hip between stress echocardiographic findings and outcome
n these series has been previously described (11,12).
tress testing. Patients were prepared for dobutamine
esting in the usual fashion: we followed a standard protocol
f dose increments to a peak dose of 40 g/kg/min (13).
linical and ECG monitoring was performed throughout
he test. Standard end points were used, with the test being
topped for severe ischemia (severe angina, 2-mm ST-
egment depression), hypertension (systolic blood pressure
220 mm Hg), hypotension (decrement of systolic blood
ressure to 100 mm Hg or with symptoms), or arrhyth-
ias. The presence of angina, ST-segment depression, and
agnitude of ST-segment depression were recorded.
chocardiography. Standard two-dimensional echocardi-
graphy was obtained at rest and after stress. Images were
nterpreted independent of clinical, stress, or angiographic
ata, and the results were made available to the physicians
Table 1. Clinical, Stress, and Echocardiograph
Echocardiography Groups
Parameter
Modeling
(n  1
Age (yrs) 62 
Males (%) 856 (5
Diabetes (%) 298 (2
Hypertension (140/80 mm Hg) (%) 572 (3
Beta-blocker (%) 275 (1
Calcium channel blocker (%) 527 (3
Digoxin (%) 182 (1
Diuretics (%) 391 (2
Angiotensin-converting enzyme
inhibitors (%)
288 (2
Maximum heart rate (beats/min) 130 
Peak rate pressure product (1,000) 19 
Low rate pressure product (15,000) 341 (2
Ischemia (with or without scar) 345 (2
Scar (with or without ischemia) 450 (3
There were no differences between the modeling and int
significantly fewer risk factors and a lower rate-pressure prod
Abbreviations and Acronyms
CAD  coronary artery disease
DbE  dobutamine echocardiography/echocardiogram
ECG  electrocardiogram/electrocardiographic
LV  left ventricular
MI  myocardial infarctionpresented as the mean value  SD or number (%) of subjects.esponsible for the patient. Based on qualitative assessment,
esting left ventricular (LV) function was evaluated as
ormal or abnormal. Regional dysfunction was required to
esignate the existence of “scar,” which was defined on the
asis of resting akinesia or severe hypokinesia. Abnormal
cans were characterized as those showing abnormal re-
ional function in one, two, or three coronary vascular
erritories. Ischemia was identified by new or worsening wall
otion abnormalities. The extent of ischemia was also
ssessed based on the anticipated territories of the three
oronary arteries.
ollow-up. The modeling and internal validation series
U.S. sites) were followed for 3.7  1.8 years, and the
xternal validation series (Dutch site) was followed for 3.0
2.0 years. A composite end point of cardiac death or MI
as used to maximize event rates in the modeling and
alidation groups. Those undergoing myocardial revascular-
zation were censored at the time of this procedure.
ollow-up was incomplete in 243 patients (5%), comprising
42 from the U.S. centers and one from the Dutch site.
tatistical analysis. Survival scores were developed by ran-
omly separating the series into modeling and validation
riables in the Dobutamine
p Internal Validation
Group (n  1,458)
External Validation
Group (n  1,733)
62  12 62  12
805 (55%) 1229 (71%)*
296 (20%) 144 (8%)*
560 (38%) 511 (29%)*
248 (17%) 380 (22%)
500 (34%) 347 (20%)*
187 (12%) 83 (10%)
415 (28%) 176 (10%)*
276 (19%) 352 (20%)
131  20 125  21
19  5 17  5†
340 (23%)
351 (24%) 557 (32%)
490 (34%) 942 (54%)
validation groups. The external validation group showed
t more scar and ischemia (*p  0.01, †p  0.001). Data are
igure 1. Distribution of patients and events into the modeling and
nternal validation groups for dobutamine echocardiography. MI  myo-
ardial infarction.ic Va
Grou
,456)
12
9%)
1%)
9%)
9%)
6%)
3%)
7%)
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5
3%)
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Risk Score With Dobutamine Echocardiography June 2, 2004:2102–7roups. The initial model for dobutamine stress was devel-
ped in 1,456 of 2,914 DbE patients studied at the U.S.
ites and applied to validation in the remainder of the
atients from these sites, as well as to the 1,733 patients
ith complete follow-up from the Dutch site.
The first step was identification of the univariate corre-
ates of events using a Cox proportional hazards model.
ariables showing an association with a value of p  0.10
ere entered into a multivariate model to identify the
ndependent correlates with subsequent events. Rather than
enerate an equation where risk could be calculated as a
ontinuous variable, but requiring calculation of exponen-
ials (which are difficult to apply in the clinic), we used the
dds ratios from this model to calculate a risk score, from
hich we classified low-, intermediate-, and high-risk
roups with five-year event-free survival rates of 95%,
5% to 95%, and 75%, respectively, selected in order to be
nalogous with the classification of the Duke treadmill
core. The equations were then applied in the internal and
xternal validation groups, allowing a comparison of the
utcomes between the modeling and validation groups.
ESULTS
atient characteristics. The patient characteristics in the
odeling and internal validation groups are compared in
able 1, which also shows equivalent data for the external
alidation group. These groups were generally well
Table 2. Independent Predictors of Events by
Group
Univariate
RR
Age 1.03
Male gender 1.4
Chest pain history 1.4
Previous myocardial infarction 1.7
History of heart failure 1.7
Previous myocardial infarction 1.7
Diabetes mellitus 0.9
Hypertension 1.7
Beta-blocker 1.2
Low workload 1.7
Peak heart rate 0.99
Abnormal DbE 4.2
Abnormality extent
Single-vessel 2.7
Two-vessel 3.2
Three-vessel 3.8
Ischemia 2.1
Ischemia extent
Single-vessel 2.0
Multivessel 2.6
Scar 2.4
Scar extent
Single-vessel 2.4
Multivessel 2.9
LV dysfunction 2.6
CI  confidence interval; DbE  dobutamine echocardiogratched. sutcomes. The outcomes of patients in the modeling and
alidation groups are summarized in Figure 1. The univar-
ate risks associated with predictors of events are expressed
n Table 2, which also summarizes the independent predic-
ors of event-free survival from the best multivariate model.
he simplification of these coefficients to single digits
llowed the development of risk scores for DbE:
Risk  (age · 0.02)  heart failure history
 rate-pressure product 15,000) · 0.4
(ischemia scar · 0.6
ith the application of this score, the presence of each
ariable was scored as 1 and its absence scored as 0, except
or age, which was entered as a continuous variable. The
implification of these parameters led to an underestimation
f risk at higher levels of risk.
Patients were classified into low-, intermediate-, and
igh-risk groups with DbE (Fig. 3) using five-year event-
ree survival rates of 95%, 75% to 95%, and 75%,
espectively. The relationship of stress and dobutamine
cores with the three outcome categories is summarized in
able 3.
utcomes in the validation group. Cardiac death or MI
efore revascularization occurred in 147 of 1,458 patients in
he internal validation group and in 494 of 1,733 patients in
he external validation group. The application of the risk
tamine Echocardiography in the Modeling
lysis Multivariate Analysis
Value RR (95% CI) p Value
.001 1.02 (1.01–1.04) 0.008
.04
.07
.007
.003 1.47 (1.06–2.04) 0.023
.003
.60
.03
.44
.002 1.44 (1.03–2.02) 0.035
.4
.0001
.0001
.0001
.0001
.0001 1.73 (1.24–2.43) 0.001
.001
.0001
.0001 1.83 (1.32–2.55) 0.001
.0001
.0001
.0001
V  left ventricular; RR  relative risk.Dobu
Ana
p
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
am; Lcores to the validation groups is illustrated in Figures 2 and
3
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June 2, 2004:2102–7 Risk Score With Dobutamine Echocardiography. These outcomes are analogous to those in the modeling
roup (C index  0.72).
ISCUSSION
he scores developed in this study can be used to classify
atients into high-, low-, and intermediate-risk groups. Be-
ause many patients undergo DbE as their primary investiga-
ion rather than an exercise test, these tools may facilitate
ational decision-making about medical management, based
n the likelihood of an adverse outcome, rather than the
urrent, more binary approach, based on a positive or negative
igure 2. Outcomes of high-, intermediate-, and low-risk groups in th
chocardiography.tress result.rognostic implications of stress imaging tests. The
erformance of a negative stress test using either nuclear
ardiology techniques (14) or stress echocardiography (11,12)
as been shown to demonstrate low levels of risk (1% per
ear). However, this risk is clearly modulated by clinical
ariables, including older age and diabetes (15). Moreover, if
he test is positive, the level of risk is determined by the clinical
etting, association with resting LV dysfunction, results of
tress testing, ischemic threshold, and extent of ischemia
9,11,12), but there is no easy way of integrating these data.
A number of large databases have been used to develop
rognostic scores with exercise testing. These account for not
deling (A) and internal validation (B) groups undergoing dobutaminee mo
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Risk Score With Dobutamine Echocardiography June 2, 2004:2102–7nly the development of ST-segment changes but also their
egree, and in some instances include angina and uniformly
nclude exercise capacity. The benefit of the scores is the
ncorporation of a number of prognostic variables that individ-
ally account for risk into a composite score where each of the
ariables is clearly represented. Although these variables are
idely recognized, a number of studies have illustrated that
hysician estimates for both diagnosis and prognosis generally
roduce less favorable results than do the scores alone, certainly
mong noncardiologists (3). Some scores have incorporated
linical risk variables into the final score, and, as might be
xpected, these simple scores, despite involving a small number
f variables, are more powerful than the scores based on stress
esting alone (4). However, to date, no study has had a
ufficient size to develop and validate a score for stress echo-
ardiography within separate groups.
The parameters entering the scores developed in this study
arrant some discussion. Notwithstanding the high risk of
iabetes in those unable to exercise (16), diabetes did not
ppear as a major independent contributor to risk in patients
ndergoing DbE, probably because an inability to exercise is a
arker of co-morbidities that contribute to poor outcomes.
ncreasing age was an important risk factor in patients under-
oing DbE, perhaps reflecting the use of this test in an older
roup where age is more likely to be a predictor of adverse
able 3. Relationship of Dobutamine Score With Outcome
Risk Category
Event-Free
at 5 Yrs
Dobutamine
Score
ow risk 97% 1.2
ntermediate risk 75%–97% 1.2–2.6
igh risk 75% 2.6Figure 3. Outcomes of high-, intermediate-, and low-risk groups in the eutcomes. Interestingly, the extent of abnormality did not
how up as an independent marker of risk; this very likely
eflects the low cardiovascular stress administered with dobut-
mine, as well as the tendency to stop the test at the onset of
schemia.
linical application of score results. The identification of
ow-risk patients has major management and thereby cost
mplications. A serious yearly event rate of 1% has been
idely applied as a yardstick to identify patient groups that
re unlikely to benefit prognostically from any form of
echanical coronary intervention, by percutaneous or sur-
ical means. The development of a composite clinical and
tress echocardiographic score enables the identification of
uch patients. For example, a 70-year-old patient with a
istory of heart failure has an intermediate risk score even
ith a negative DbE. Thus, the application of this compos-
te score, rather than the results of stress echocardiography
lone, may further streamline the allocation of low risk to
ndividuals who do not require further investigation, while
ot compromising a few individuals without ischemia who
re at risk and warrant further consideration.
The traditional angiographic criteria of risk readily ad-
ress the extremes of high and low risk in patients with left
ain and triple-vessel disease with LV dysfunction (17),
ompared with no disease, but leaves individuals with
ultivessel disease at an intermediate risk. A high-risk
tress echocardiographic score confers an event rate of 5%
er year, analogous to that of patients with extensive CAD,
n whom myocardial revascularization is indicated on prog-
ostic grounds. The identification of high risk with dobut-
mine stress would be dependent on the identification of an
bnormal stress test result. Nonetheless, the combination ofxternal validation group undergoing dobutamine echocardiography.
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June 2, 2004:2102–7 Risk Score With Dobutamine Echocardiographypatient’s abnormal result with clinical markers of risk is an
mportant predictor of high risk and may be useful in
acilitating decision-making regarding revascularization.
tudy limitations. The most important limitation of this
tudy is that decision-making was likely colored by the test
esults. Although the original studies were performed early in
he history of stress echocardiography, and prognostic data at
hat time would have been insufficient to directly justify
ecisions regarding revascularization, the test results would
ave influenced further investigation and thereby indirectly
uided revascularization decisions. Consequently, the risk as-
ociated with a positive test result is likely underestimated, as
he performance of revascularization may have reduced the risk
n these patients. This limitation is inherent in such an
bservational study, and a large follow-up trial with the
rdering physicians’ results blinded to the final results is
nlikely to be performed.
The selection of end points is frequently a matter of
iscussion in prognostic studies. Our selection of a compos-
te end point of cardiac death or MI was used partly because
f its wide usage in the prognostic literature and partly to
aximize event rates in the modeling and validation groups.
he relative risk with each of the variables is similar to that
ormerly reported using total mortality and cardiac mortality
lone.
Finally, this study was performed at three large tertiary or
uaternary referral centers—a feature it shares with most of
he published data in this field. As such, its applicability to
general population of patients referred for DbE is not
nown.
onclusions. The prognostic scores developed and vali-
ated in this study may be used to facilitate clinical
ecision-making in patients with known or suspected CAD,
ased on an individualized assessment of risk.
eprint requests and correspondence: Dr. Thomas H. Mar-
ick, University Department of Medicine, Princess Alexandra
ospital, Brisbane, Qld 4102, Australia. E-mail: tmarwick@
edicine.pa.uq.edu.au.
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